Carnegie acted co-manager in connection with Calliditas initial public offering in the United States. Calliditas Therapeutics is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which the Company can partially or completely participate in the commercialization efforts. June 2020.
Healthcare
Initial public offering of Calliditas Therapeutics AB (SE) on The Nasdaq Global Select Market US – USD 90 million
June 2020